Nephrotic range proteinuria in an adolescent with a diagnosis of Wilson’s disease: Answers
暂无分享,去创建一个
[1] H. El-karaksy,et al. Urinary abnormalities in children and adolescents with Wilson disease before and during treatment with d‐penicillamine , 2019, Journal of gastroenterology and hepatology.
[2] J. Kim,et al. A Pediatric Case of a D-Penicillamine Induced ANCA-associated Vasculitis Manifesting a Pulmonary-Renal Syndrome , 2019, Journal of Korean medical science.
[3] S. Kaliaperumal,et al. Wilson disease and lupus nephritis: is it coincidence or a true association? , 2019, Paediatrics and international child health.
[4] Takuto Maeda,et al. Immunoglobulin A nephropathy secondary to Wilson’s disease: a case report and literature review , 2018, CEN Case Reports.
[5] Xuejun Zeng,et al. Wilson’s disease combined with systemic lupus erythematosus: a case report and literature review , 2018, BMC Neurology.
[6] N. Mamoon,et al. Immunoglobulin M Nephropathy in a Patient with Wilson’s Disease , 2016, Cureus.
[7] Heeyeon Cho,et al. D-penicillamine-induced ANA (+) ANCA (+) vasculitis in pediatric patients with Wilson's disease. , 2016, Clinical nephrology.
[8] H. Geng,et al. A special case of recurrent gross hematuria: Answers , 2017, Pediatric Nephrology.
[9] S. Mukhopadhyay,et al. Refractory rickets due to Fanconi's Syndrome secondary to Wilson's disease , 2012, Indian journal of endocrinology and metabolism.
[10] S. Leonardi,et al. Hypercalciuria and Nephrocalcinosis as Early Feature of Wilson Disease Onset: Description of a Pediatric Case and Literature Review , 2012, Hepatitis monthly.
[11] G. Nebbia,et al. Wilson's disease treated with penicillamine and lupus erythematosus: related or distinct entities? , 2012, Minerva pediatrica.
[12] S. Menon,et al. Membranous nephropathy in children: clinical presentation and therapeutic approach , 2009, Pediatric Nephrology.
[13] Elizabeth A. Kruse,et al. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis , 2009, Nature.
[14] Xiaoyun Jiang,et al. Analysis of renal impairment in children with Wilson’s disease , 2008, World journal of pediatrics : WJP.
[15] G. Habib,et al. Penicillamine and nephrotic syndrome. , 2006, European journal of internal medicine.
[16] C. Madl,et al. Wilson Disease , 2005, Metabolic Brain Disease.
[17] M. Harada,et al. Wilson disease , 2002, Medical Electron Microscopy.
[18] P. Galle,et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1 /Fas) Mediated apoptosis , 1998, Nature Medicine.
[19] A. Anarat,et al. Wilson cirrhosis associated with membranoproliferative glomerulonephritis. , 1996, Nephron.
[20] H. Nazer,et al. Wilson's Disease. , 1991, Annals of Saudi medicine.
[21] P. Bacon,et al. Natural course of penicillamine nephropathy: a long term study of 33 patients , 1988, British medical journal.
[22] M. Seelig. Penicillamine and the nephrotic syndrome. , 1967, JAMA.
[23] J. Walshe. Wilson's disease; new oral therapy. , 1956, The Lancet.